INVITATION FOR TECHNOLOGICAL COOPERATION
Company: CATO RESEARCH ISRAEL LTD.
DOCUMENT STRUCTURE:
CONTACT DATA
| Organization: | CATO RESEARCH ISRAEL LTD. |
| Contact: |
Name: Dr. Heschi Rotmensch Position: Senior VP Drug Development |
| Address: |
2 Habarzel St. Tel Aviv ISRAEL, 69710 Telephone: 03-6449522 Fax: 03-6449523 Email: catoisrael@cato.co.il WEB site: www.cato.com |
GENERAL INFORMATION
Established: 1995
Type:
Contract Research Organization
Ownership: Private
Core business
A contract research and development organization to help
Employees: 18 Overview
CATO RESEARCH ISRAEL LTD. (CRI), is an Israeli division of
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
pharmaceutical and biotechnology companies design and execute
successful development strategies.
international, privately owned company CATO Research, founded in
1988, as a Contract Research Organization (CRO) with offices
throughout the United States, Canada, South Africa, Israel and
Europe.
CATO RESEARCH ISRAEL was established in 1995, providing
integrated services to pharmaceutical, biotechnology and medical
device companies and supporting them in all aspects of drug
development and clinical trials.
As a mid sized CRO, CATO is particularly well suited to providing
personalized, client -oriented services. CATO is a quality and
solution - driven company at the forefront of the industry,
utilizing cutting - edge technologies and processes to meet the
most demanding needs.
Clinical Trials
CATO identifies and adopts efficient processes and practices for
the conduct and management of clinical trials, utilizing
state-of-the-art tools that ensure rapid site activation,
proactive enrollment management, and high quality monitoring.
The majority of CATO's clinical and management staff are
medically trained and ACRP certified and obtain ongoing
therapeutic area, regulatory and safety training. CATO's services
range from protocol development to writing final study report
across a wide variety of therapeutic areas.
MATIMOP ADDRESS:
Liaison: Mr. Uzi Bar-Sadeh
Internet site: http://www.matimop.org.il
Email: uzi@matimop.org.il
Mail: POBox: 50364 Tel Aviv Israel 61 500
Fax: ++ 972 3 5177655